Business Trends– category –
-
ECHO Implant: Drug-Free Diabesity Treatment via Electrocatalysis
Mirage News (AAAS / Science) USA Overview Researchers have developed ECHO, a wirelessly powered implantable device that uses electrocatalysis to remove excess blood glucose without medication. In tests with obese type 2 diabetic mice, th... -
Scinai CDMO Expansion: $5.1 Million Clinical Manufacturing Deal
PR Newswire USA Overview Scinai Immunotherapeutics has secured a $5.1 million development and clinical manufacturing agreement with a Nasdaq-listed U.S. biopharmaceutical company. This deal contributes to a total of approximately $7.6 mi... -
Senseonics and Beta Bionics: iLet CGM Integration and Timeline
MedTech Dive USA Overview Senseonics and Beta Bionics have entered a non-monetary partnership to integrate the Eversense 365 implantable CGM with the iLet automated insulin delivery (AID) system. Targeted for a Q4 2026 launch, the deal f... -
Liverpool School of Tropical Medicine Launches £4.5M Partnership for Neglected Tropical Diseases, Featuring Wearable Microwave Biosensors
Liverpool School of Tropical Medicine (LSTM) UK Overview The Liverpool School of Tropical Medicine (LSTM) has announced "ENDPOINT," a new £4.5 million partnership funded by UK aid, targeting the elimination of lymphatic filariasis and on... -
Profusa Announces Significant Progress Towards Lumee® Oxygen Platform CE Mark Following Positive ISO 13485 Certification Decision
Markets Insider (GlobeNewswire) USA Overview Digital health company Profusa announced significant progress towards obtaining CE Mark for its Lumee® Oxygen Platform, having received a positive decision from GMED regarding ISO 13485 certif... -
FDA Approves Firmware Update for Dexcom G5 Mobile Continuous Glucose Monitoring System
FDA.gov USA Overview The U.S. FDA has approved minor design changes to the firmware installed on the transmitter component of the Dexcom G5 Mobile Continuous Glucose Monitoring System. Issued as a Premarket Approval (PMA) supplement, thi...
1